Skip to content

Clinical efficacy of rTMS combined with MI on upper limb function recovery after stroke based on EEG

Clinical efficacy of rTMS combined with MI on upper limb function recovery after stroke based on EEG

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500114528
Enrollment
Unknown
Registered
2025-12-15
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Study Group 2:rTMS+Conventional rehabilitation
Study Group 1:rTMS+Motor Imagery Training+Conventional rehabilitation
Control Group:Conventional rehabilitation

Sponsors

The First Affiliated Hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Meets the World Health Organization (WHO) diagnostic criteria for stroke and confirmed by imaging examinations; 2. First onset, unilateral stroke (lesion in the left/right cerebral hemisphere), disease duration of 1-6 months; 3. Aged 40-75 years, any gender; 4. Conscious, cognitive function acceptable (Mini-Mental State Examination score >=24), able to cooperate with interventions and assessments; 5. National Institutes of Health Stroke Scale (NIHSS) score <=15 (indicating mild to moderate neurological deficits, ensuring the patient has basic cooperation ability and rehabilitation potential); 6. Affected upper limb has passive range of motion (PROM) without significant joint contracture or pain (visual analog scale =3); 7. Signed informed consent and voluntarily participates in this study.

Exclusion criteria

Exclusion criteria: 1. Presence of rTMS contraindications (such as intracranial metal implants, history of epilepsy, severe heart disease, etc.); 2. Severe cognitive impairment (Mini-Mental State Examination score <24), psychiatric disorders, or language disorders making it impossible to cooperate with training; 3. Severe muscle atrophy, fractures, joint dislocations, or other orthopedic conditions affecting motor function in the affected limb; 4. Received other neurointervention treatments such as transcranial magnetic stimulation or electrical brain stimulation within the past 3 months; 5. Pregnant or breastfeeding women; 6. Severe liver or kidney dysfunction, infectious diseases, or other systemic diseases that may affect the study process.

Design outcomes

Primary

MeasureTime frame
Fugl-Meyer Assessment for Upper Extremity Function (FMA-UE);Resting State Power Spectral Density (PSD);

Secondary

MeasureTime frame
Self-Rating Anxiety (SAS);Barthel Index (BI);Action Research Arm Test (ARAT);Self-Rating Depression (SDS);

Countries

China

Contacts

Public ContactGong Xiaoyang

The First Affiliated Hospital of Dalian Medical University

gongxiaoyang@firsthosp-dmu.com+86 411 83635963

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026